Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer
A Phase I Study of Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer
Sponsor: University of Texas Southwestern Medical Center
This PHASE1 trial investigates Early Stage Breast Cancer and is currently completed. University of Texas Southwestern Medical Center leads this study, which shows 9 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE1
-
Mar 2019 — Sep 2020 [monthly]
Completed PHASE1
▶ Show 4 earlier versions
-
Feb 2019 — Mar 2019 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE1
-
Dec 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE1
-
Jan 2017 — Dec 2017 [monthly]
Active Not Recruiting PHASE1
First recorded
Oct 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .